This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe

BPI Europe is in

  • 00
  • 00
  • 00
  • 00
Attend Our Upcoming Hybrid Event held 17-20 May 2022!
Messe Wien Congress CentreVienna

Benjamin Linder
Data Scientist at Boehringer Ingelheim


Dr. Lindner thrives the implementation of Next Generation Sequencing (NGS) technology into cell line characterization. Trained as a biochemist, he gained over 10 years’ experience of next and third generation sequencing technologies. Over 5 years he spent developing NGS applications including DNA-seq, RNA-seq and bisulfite-seq at GATC Biotech, Europe’s leading sequencing service provider at that time. Since 2017 he developed pooled CRISPR screens and single cell RNA-seq to identify regulators of phagocytosis at Boehringer Ingelheim. More recently, he implemented RNA-seq for sequence variant detection in early-stage development of CHO cell line generation.

Agenda Sessions

  • Localization and structural characterization of random transgene integration of CHO manufacturing clones using next generation sequencing